Bibliographic Info
GuidelineAntiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings : towards universal access : recommendations for a public health approach
Year of Publication2006
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
High
Efavirenz should be used as the preferred non-nucleoside reverse transcriptase inhibitor in patients starting ART while on antituberculosis treatment
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO policy on collaborative TB/HIV activities : guidelines for national programmes and other stakeholders
Year2012
InstitutionWHO